NICE OK for life-extending Vizimpro in lung cancer

5th July 2019 Uncategorised 0

It’s a change from the committee’s initial decision which found the tyrosine kinase inhibitor to not be a cost-effective use of NHS resources.

More: NICE OK for life-extending Vizimpro in lung cancer
Source: News